Compare INBX & NEWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INBX | NEWP |
|---|---|---|
| Founded | 2010 | 1972 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2024 | 2006 |
| Metric | INBX | NEWP |
|---|---|---|
| Price | $100.50 | $6.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $150.00 | $6.00 |
| AVG Volume (30 Days) | 309.3K | ★ 739.0K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 550.00 | N/A |
| 52 Week Low | $28.16 | $1.98 |
| 52 Week High | $155.29 | $7.55 |
| Indicator | INBX | NEWP |
|---|---|---|
| Relative Strength Index (RSI) | 41.24 | 56.84 |
| Support Level | $99.20 | $3.44 |
| Resistance Level | $106.40 | $7.55 |
| Average True Range (ATR) | 8.26 | 0.36 |
| MACD | -2.20 | 0.04 |
| Stochastic Oscillator | 16.95 | 79.54 |
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.